Advanced Search (OLGA)

Gene: FAM83F (family with sequence similarity 83 member F) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

FAM83F

Name:

family with sequence similarity 83 member F

RGD ID:

1602306

HGNC Page

HGNC:25148

Description:

Predicted to enable protein kinase binding activity. Predicted to be involved in signal transduction.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

family with sequence similarity 83, member F; hypothetical protein LOC113828

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	22	39,994,954 - 40,043,534 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	22	39,994,954 - 40,043,534 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	22	40,390,958 - 40,439,538 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	22	38,720,899 - 38,755,989 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	22	24,192,998 - 24,228,085 (+)	NCBI		Celera
Cytogenetic Map	22	q13.1	NCBI
HuRef	22	23,353,893 - 23,389,299 (+)	NCBI		HuRef
CHM1_1	22	40,350,160 - 40,385,346 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	22	40,465,916 - 40,515,097 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
FAM83F	Human	adenylosuccinase lyase deficiency		IAGP	RGD:151724114\|RGD:156447560	8554872	ClinVar Annotator: match by term: Adenylosuccinate lyase deficiency	ClinVar	PMID:28492532
FAM83F	Human	Asthenozoospermia		IAGP	RGD:156038950	8554872	ClinVar Annotator: match by term: asthenozoospermia	ClinVar	PMID:25741868
FAM83F	Human	oligospermia		IAGP	RGD:156038950	8554872	ClinVar Annotator: match by term: Oligospermia	ClinVar	PMID:25741868
FAM83F	Human	Rubinstein-Taybi syndrome		IAGP	RGD:405874299	8554872	ClinVar Annotator: match by term: Rubinstein-Taybi syndrome 2	ClinVar	PMID:28492532
FAM83F	Human	Teratozoospermia		IAGP	RGD:156038950	8554872	ClinVar Annotator: match by term: Teratozoospermia	ClinVar	PMID:25741868

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
FAM83F	Human	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1618184	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM83F mRNA	CTD	PMID:36331819
FAM83F	Human	(S)-nicotine	increases expression	EXP		6480464	Nicotine results in increased expression of FAM83F mRNA	CTD	PMID:23825647
FAM83F	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618184	6480464	Tetrachlorodibenzodioxin affects the expression of FAM83F mRNA	CTD	PMID:26377647
FAM83F	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1562089	6480464	Tetrachlorodibenzodioxin results in increased expression of FAM83F mRNA	CTD	PMID:33387578
FAM83F	Human	2-hydroxypropanoic acid	increases expression	EXP		6480464	Lactic Acid results in increased expression of FAM83F mRNA	CTD	PMID:30851411
FAM83F	Human	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1562089	6480464	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FAM83F mRNA	CTD	PMID:32119087
FAM83F	Human	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1562089	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ...	CTD	PMID:36041667
FAM83F	Human	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1562089	6480464	Propylthiouracil results in decreased expression of FAM83F mRNA	CTD	PMID:25825206
FAM83F	Human	aflatoxin B1	increases expression	ISO	RGD:1562089	6480464	Aflatoxin B1 results in increased expression of FAM83F mRNA	CTD	PMID:23630614
FAM83F	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of FAM83F intron	CTD	PMID:30157460
FAM83F	Human	Aflatoxin B2 alpha	increases methylation	EXP		6480464	aflatoxin B2 results in increased methylation of FAM83F intron	CTD	PMID:30157460
FAM83F	Human	Aflatoxin B2 alpha	decreases methylation	EXP		6480464	aflatoxin B2 results in decreased methylation of FAM83F exon	CTD	PMID:30157460
FAM83F	Human	atrazine	increases expression	EXP		6480464	Atrazine results in increased expression of FAM83F mRNA	CTD	PMID:22378314
FAM83F	Human	benzo[a]pyrene	decreases methylation	EXP		6480464	Benzo(a)pyrene results in decreased methylation of FAM83F 5' UTR; Benzo(a)pyrene results in decreased methylation of more ...	CTD	PMID:27901495
FAM83F	Human	benzo[a]pyrene	increases expression	ISO	RGD:1618184	6480464	Benzo(a)pyrene results in increased expression of FAM83F mRNA	CTD	PMID:32417428
FAM83F	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of FAM83F intron	CTD	PMID:30157460
FAM83F	Human	benzo[e]pyrene	decreases methylation	EXP		6480464	benzo(e)pyrene results in decreased methylation of FAM83F exon; benzo(e)pyrene results in decreased methylation of FAM83F more ...	CTD	PMID:30157460
FAM83F	Human	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1618184	6480464	Diethylhexyl Phthalate results in decreased expression of FAM83F mRNA	CTD	PMID:34319233
FAM83F	Human	bisphenol A	decreases expression	ISO	RGD:1618184	6480464	bisphenol A results in decreased expression of FAM83F mRNA	CTD	PMID:33221593
FAM83F	Human	bisphenol A	multiple interactions	ISO	RGD:1562089	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ...	CTD	PMID:36041667
FAM83F	Human	bisphenol F	multiple interactions	ISO	RGD:1562089	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ...	CTD	PMID:36041667
FAM83F	Human	bromobenzene	increases expression	ISO	RGD:1562089	6480464	bromobenzene results in increased expression of FAM83F mRNA	CTD	PMID:32479839
FAM83F	Human	cadmium dichloride	decreases expression	EXP		6480464	Cadmium Chloride results in decreased expression of FAM83F mRNA	CTD	PMID:38382870\|PMID:38568856
FAM83F	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to FAM83F gene]	CTD	PMID:28238834
FAM83F	Human	copper atom	multiple interactions	ISO	RGD:1562089	6480464	[Copper co-treated with Dietary Sucrose] results in increased expression of FAM83F mRNA	CTD	PMID:26033743
FAM83F	Human	copper atom	increases expression	ISO	RGD:1562089	6480464	Copper deficiency results in increased expression of FAM83F mRNA	CTD	PMID:26033743
FAM83F	Human	copper(0)	multiple interactions	ISO	RGD:1562089	6480464	[Copper co-treated with Dietary Sucrose] results in increased expression of FAM83F mRNA	CTD	PMID:26033743
FAM83F	Human	copper(0)	increases expression	ISO	RGD:1562089	6480464	Copper deficiency results in increased expression of FAM83F mRNA	CTD	PMID:26033743
FAM83F	Human	cylindrospermopsin	increases expression	EXP		6480464	cylindrospermopsin results in increased expression of FAM83F mRNA	CTD	PMID:24921660
FAM83F	Human	dibutyl phthalate	decreases expression	ISO	RGD:1618184	6480464	Dibutyl Phthalate results in decreased expression of FAM83F mRNA	CTD	PMID:21266533
FAM83F	Human	dichloroacetic acid	increases expression	ISO	RGD:1618184	6480464	Dichloroacetic Acid results in increased expression of FAM83F mRNA	CTD	PMID:28962523
FAM83F	Human	dimethylselenide	multiple interactions	EXP		6480464	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT more ...	CTD	PMID:33656867
FAM83F	Human	diuron	increases expression	ISO	RGD:1562089	6480464	Diuron results in increased expression of FAM83F mRNA	CTD	PMID:25152437
FAM83F	Human	fenvalerate	increases expression	ISO	RGD:1562089	6480464	fenvalerate results in increased expression of FAM83F mRNA	CTD	PMID:30307764
FAM83F	Human	furan	increases expression	ISO	RGD:1562089	6480464	furan results in increased expression of FAM83F mRNA	CTD	PMID:25539665\|PMID:27387713
FAM83F	Human	gentamycin	increases expression	ISO	RGD:1562089	6480464	Gentamicins results in increased expression of FAM83F mRNA	CTD	PMID:33387578
FAM83F	Human	hydroxyl	multiple interactions	EXP		6480464	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT more ...	CTD	PMID:33656867
FAM83F	Human	inulin	multiple interactions	ISO	RGD:1618184	6480464	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of FAM83F mRNA	CTD	PMID:36331819
FAM83F	Human	lenalidomide	multiple interactions	EXP		6480464	lenalidomide results in increased degradation of and results in decreased expression of FAM83F protein	CTD	PMID:30067223
FAM83F	Human	methapyrilene	decreases methylation	EXP		6480464	Methapyrilene results in decreased methylation of FAM83F exon; Methapyrilene results in decreased methylation of FAM83F more ...	CTD	PMID:30157460
FAM83F	Human	nicotine	increases expression	EXP		6480464	Nicotine results in increased expression of FAM83F mRNA	CTD	PMID:23825647
FAM83F	Human	ozone	multiple interactions	EXP		6480464	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA] more ...	CTD	PMID:33656867
FAM83F	Human	PCB138	decreases expression	ISO	RGD:1562089	6480464	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FAM83F mRNA	CTD	PMID:23829299
FAM83F	Human	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618184	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM83F mRNA; [perfluorooctane sulfonic more ...	CTD	PMID:36331819
FAM83F	Human	phenobarbital	affects expression	ISO	RGD:1618184	6480464	Phenobarbital affects the expression of FAM83F mRNA	CTD	PMID:23091169
FAM83F	Human	pomalidomide	multiple interactions	EXP		6480464	pomalidomide results in increased degradation of and results in decreased expression of FAM83F protein	CTD	PMID:30067223
FAM83F	Human	rac-lactic acid	increases expression	EXP		6480464	Lactic Acid results in increased expression of FAM83F mRNA	CTD	PMID:30851411
FAM83F	Human	thioacetamide	increases expression	ISO	RGD:1562089	6480464	Thioacetamide results in increased expression of FAM83F mRNA	CTD	PMID:23411599
FAM83F	Human	titanium dioxide	decreases methylation	ISO	RGD:1618184	6480464	titanium dioxide results in decreased methylation of FAM83F gene; titanium dioxide results in decreased methylation more ...	CTD	PMID:35295148
FAM83F	Human	triclosan	decreases expression	EXP		6480464	Triclosan results in decreased expression of FAM83F mRNA	CTD	PMID:30510588
FAM83F	Human	valproic acid	affects expression	ISO	RGD:1618184	6480464	Valproic Acid affects the expression of FAM83F mRNA	CTD	PMID:17292431\|PMID:17963808
FAM83F	Human	valproic acid	increases expression	EXP		6480464	Valproic Acid results in increased expression of FAM83F mRNA	CTD	PMID:23179753
FAM83F	Human	valproic acid	increases methylation	EXP		6480464	Valproic Acid results in increased methylation of FAM83F gene	CTD	PMID:29154799
FAM83F	Human	valproic acid	increases expression	ISO	RGD:1562089	6480464	Valproic Acid results in increased expression of FAM83F mRNA	CTD	PMID:35594946

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
FAM83F	Human	signal transduction	involved_in	IBA	PANTHER:PTN008563846\|UniProtKB:A6ND36\|UniProtKB:Q86UY5	150520179		GO_Central	GO_REF:0000033

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
FAM83F	Human	protein binding	enables	IPI	UniProtKB:P48729	150520179	PMID:29789297	IntAct	PMID:29789297
FAM83F	Human	protein kinase binding	enables	IBA	PANTHER:PTN008563846\|UniProtKB:Q2M2I3\|UniProtKB:Q5T0W9\|UniProtKB:Q6ZRV2\|UniProtKB:Q86UY5\|UniProtKB:Q9BQN1\|UniProtKB:Q9H4H8	150520179		GO_Central	GO_REF:0000033

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
FAM83F	Human	Abnormal sperm morphology		IAGP	RGD:156038950	8554872	ClinVar Annotator: match by term: Abnormal sperm morphology	ClinVar	PMID:25741868

#	Reference Title	Reference Citation
1.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:12477932	PMID:17342744	PMID:19322201	PMID:19834535	PMID:21873635	PMID:29789297	PMID:30280778	PMID:30556880	PMID:30639242	PMID:30692643	PMID:30881348	PMID:31586073
PMID:31595558	PMID:33361109	PMID:33361334	PMID:33560141	PMID:33961781	PMID:35748872	PMID:36526897

FAM83F
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	22	39,994,954 - 40,043,534 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	22	39,994,954 - 40,043,534 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	22	40,390,958 - 40,439,538 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	22	38,720,899 - 38,755,989 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	22	24,192,998 - 24,228,085 (+)	NCBI		Celera
Cytogenetic Map	22	q13.1	NCBI
HuRef	22	23,353,893 - 23,389,299 (+)	NCBI		HuRef
CHM1_1	22	40,350,160 - 40,385,346 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	22	40,465,916 - 40,515,097 (+)	NCBI		T2T-CHM13v2.0

Fam83f
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	15	80,555,829 - 80,584,626 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	15	80,556,048 - 80,584,626 (+)	Ensembl		GRCm39 Ensembl
GRCm38	15	80,671,847 - 80,700,425 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	15	80,671,847 - 80,700,425 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	15	80,502,277 - 80,530,855 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	15	80,499,124 - 80,527,679 (+)	NCBI		MGSCv36	mm8
Celera	15	82,791,708 - 82,820,290 (+)	NCBI		Celera
Cytogenetic Map	15	E1	NCBI
cM Map	15	37.89	NCBI

Fam83f
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	7	114,091,356 - 114,120,640 (+)	NCBI		GRCr8
mRatBN7.2	7	112,211,164 - 112,240,454 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	7	112,211,164 - 112,240,452 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	7	113,967,194 - 113,996,023 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	7	116,190,732 - 116,219,560 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	7	116,160,102 - 116,188,931 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	7	121,889,157 - 121,918,772 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	7	121,889,157 - 121,918,772 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	7	121,880,994 - 121,910,618 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	7	118,951,184 - 118,980,287 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	7	108,535,286 - 108,564,517 (+)	NCBI		Celera
Cytogenetic Map	7	q34	NCBI

Fam83f
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955413	25,775,107 - 25,807,625 (+)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955413	25,775,107 - 25,807,592 (+)	NCBI	ChiLan1.0	ChiLan1.0

FAM83F
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	23	49,841,110 - 49,964,770 (+)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	22	52,532,389 - 52,581,004 (+)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	22	20,900,012 - 20,948,588 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	22	38,719,795 - 38,754,415 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	22	38,719,795 - 38,753,949 (+)	Ensembl	panpan1.1		panPan2

FAM83F
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	10	25,106,663 - 25,140,989 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	10	25,108,003 - 25,140,989 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	10	25,042,836 - 25,077,209 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	10	25,858,698 - 25,893,092 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	10	25,860,038 - 25,893,564 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	10	25,570,358 - 25,604,718 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	10	25,892,937 - 25,927,326 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	10	26,067,408 - 26,101,823 (-)	NCBI		UU_Cfam_GSD_1.0

Fam83f
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024404945	8,696,599 - 8,729,416 (-)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936492	1,713,327 - 1,739,823 (-)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936492	1,697,759 - 1,739,830 (-)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

FAM83F
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	5	8,319,203 - 8,354,723 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	5	8,320,972 - 8,354,738 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	5	5,617,726 - 5,647,746 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

FAM83F
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	19	22,572,387 - 22,606,348 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	19	22,572,483 - 22,605,897 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666045	102,990,865 - 103,027,133 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Fam83f
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624752	8,406,436 - 8,438,950 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624752	8,403,619 - 8,438,975 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in FAM83F
65 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 22q12.3-13.33(chr22:33768441-50739977)x3	copy number gain	See cases [RCV000051682]	Chr22:33768441..50739977 [GRCh38] Chr22:34164428..51178405 [GRCh37] Chr22:32494428..49525271 [NCBI36] Chr22:22q12.3-13.33	pathogenic
GRCh38/hg38 22q12.3-13.33(chr22:37061769-50738932)x3	copy number gain	See cases [RCV000051684]	Chr22:37061769..50738932 [GRCh38] Chr22:37457809..51177360 [GRCh37] Chr22:35787755..49524226 [NCBI36] Chr22:22q12.3-13.33	pathogenic
GRCh38/hg38 22q13.1-13.2(chr22:37721797-40860953)x3	copy number gain	See cases [RCV000051685]	Chr22:37721797..40860953 [GRCh38] Chr22:38117804..41256957 [GRCh37] Chr22:36447750..39586903 [NCBI36] Chr22:22q13.1-13.2	pathogenic
GRCh38/hg38 22q11.1-13.33(chr22:16916608-50739836)x3	copy number gain	See cases [RCV000133646]	Chr22:16916608..50739836 [GRCh38] Chr22:17397498..51178264 [GRCh37] Chr22:15777498..49525130 [NCBI36] Chr22:22q11.1-13.33	pathogenic
GRCh38/hg38 22q11.1-13.33(chr22:16916743-50739785)x3	copy number gain	See cases [RCV000134730]	Chr22:16916743..50739785 [GRCh38] Chr22:17397633..51178213 [GRCh37] Chr22:15777633..49525079 [NCBI36] Chr22:22q11.1-13.33	pathogenic
GRCh37/hg19 22q11.1-13.33(chr22:16054691-51237518)x3	copy number gain	See cases [RCV000240091]	Chr22:16054691..51237518 [GRCh37] Chr22:22q11.1-13.33	pathogenic
GRCh37/hg19 22q12.3-13.33(chr22:35728929-51220961)x3	copy number gain	See cases [RCV000240469]	Chr22:35728929..51220961 [GRCh37] Chr22:22q12.3-13.33	pathogenic
GRCh37/hg19 22q13.1-13.33(chr22:40425714-51220961)x3	copy number gain	See cases [RCV000240459]	Chr22:40425714..51220961 [GRCh37] Chr22:22q13.1-13.33	pathogenic
GRCh37/hg19 22q11.1-13.33(chr22:16054691-51220902)x3	copy number gain	See cases [RCV000446956]	Chr22:16054691..51220902 [GRCh37] Chr22:22q11.1-13.33	pathogenic
GRCh37/hg19 22q13.1-13.2(chr22:40233644-41655673)x3	copy number gain	See cases [RCV000448955]	Chr22:40233644..41655673 [GRCh37] Chr22:22q13.1-13.2	uncertain significance
GRCh37/hg19 22q11.1-13.33(chr22:16054691-51237463)x3	copy number gain	See cases [RCV000448847]	Chr22:16054691..51237463 [GRCh37] Chr22:22q11.1-13.33	pathogenic
GRCh37/hg19 22q11.1-13.33(chr22:16888900-51197838)	copy number gain	See cases [RCV000510873]	Chr22:16888900..51197838 [GRCh37] Chr22:22q11.1-13.33	pathogenic
NM_138435.4(FAM83F):c.650G>A (p.Arg217Gln)	single nucleotide variant	not specified [RCV004285794]	Chr22:40019328 [GRCh38] Chr22:40415332 [GRCh37] Chr22:22q13.1	uncertain significance
GRCh37/hg19 22q11.1-13.33(chr22:16888900-51197838)x3	copy number gain	See cases [RCV000512333]	Chr22:16888900..51197838 [GRCh37] Chr22:22q11.1-13.33	pathogenic
GRCh37/hg19 22q11.1-13.33(chr22:16054667-51243435)x3	copy number gain	not provided [RCV000741689]	Chr22:16054667..51243435 [GRCh37] Chr22:22q11.1-13.33	pathogenic
GRCh37/hg19 22q11.1-13.33(chr22:16114244-51195728)x3	copy number gain	not provided [RCV000741691]	Chr22:16114244..51195728 [GRCh37] Chr22:22q11.1-13.33	pathogenic
GRCh37/hg19 22q13.1(chr22:40417604-40417964)x1	copy number loss	not provided [RCV000741978]	Chr22:40417604..40417964 [GRCh37] Chr22:22q13.1	benign
GRCh37/hg19 22q11.1-13.33(chr22:16114244-51211392)x3	copy number gain	not provided [RCV000741692]	Chr22:16114244..51211392 [GRCh37] Chr22:22q11.1-13.33	pathogenic
GRCh37/hg19 22q11.1-13.33(chr22:16888899-51197838)x3	copy number gain	not provided [RCV000846344]	Chr22:16888899..51197838 [GRCh37] Chr22:22q11.1-13.33	pathogenic
NM_138435.4(FAM83F):c.118G>C (p.Gly40Arg)	single nucleotide variant	not specified [RCV004292981]	Chr22:39995160 [GRCh38] Chr22:40391164 [GRCh37] Chr22:22q13.1	uncertain significance
GRCh37/hg19 22q12.2-13.33(chr22:30654764-51197838)x3	copy number gain	not provided [RCV001007181]	Chr22:30654764..51197838 [GRCh37] Chr22:22q12.2-13.33	pathogenic
GRCh37/hg19 22q11.1-13.33(chr22:16197005-51224252)x3	copy number gain	See cases [RCV001263056]	Chr22:16197005..51224252 [GRCh37] Chr22:22q11.1-13.33	pathogenic
NC_000022.10:g.(?_39621728)_(41077932_?)dup	duplication	Adenylosuccinate lyase deficiency [RCV001910122]	Chr22:39621728..41077932 [GRCh37] Chr22:22q13.1-13.2	uncertain significance
NC_000022.10:g.(?_35776672)_(42486826_?)dup	duplication	Adenylosuccinate lyase deficiency [RCV003119093]	Chr22:35776672..42486826 [GRCh37] Chr22:22q12.3-13.2	uncertain significance
NM_138435.4(FAM83F):c.857C>T (p.Thr286Met)	single nucleotide variant	not specified [RCV004331796]	Chr22:40021367 [GRCh38] Chr22:40417371 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.812A>T (p.Asn271Ile)	single nucleotide variant	not specified [RCV004156444]	Chr22:40021322 [GRCh38] Chr22:40417326 [GRCh37] Chr22:22q13.1	uncertain significance
GRCh37/hg19 22q13.1-13.2(chr22:40131240-41556564)x1	copy number loss	not provided [RCV002473952]	Chr22:40131240..41556564 [GRCh37] Chr22:22q13.1-13.2	pathogenic
NM_138435.4(FAM83F):c.565C>T (p.Arg189Trp)	single nucleotide variant	not specified [RCV004191159]	Chr22:40019243 [GRCh38] Chr22:40415247 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.457G>C (p.Val153Leu)	single nucleotide variant	not specified [RCV004235916]	Chr22:39995499 [GRCh38] Chr22:40391503 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.422C>T (p.Pro141Leu)	single nucleotide variant	not specified [RCV004136765]	Chr22:39995464 [GRCh38] Chr22:40391468 [GRCh37] Chr22:22q13.1	uncertain significance
GRCh37/hg19 22q13.1-13.2(chr22:39768795-41946225)x3	copy number gain	not provided [RCV002475709]	Chr22:39768795..41946225 [GRCh37] Chr22:22q13.1-13.2	uncertain significance
NM_138435.4(FAM83F):c.895G>A (p.Asp299Asn)	single nucleotide variant	not specified [RCV004163914]	Chr22:40021405 [GRCh38] Chr22:40417409 [GRCh37] Chr22:22q13.1	likely benign
NM_138435.4(FAM83F):c.671G>A (p.Arg224His)	single nucleotide variant	Abnormal sperm morphology [RCV003154282]\|not specified [RCV004227613]	Chr22:40019900 [GRCh38] Chr22:40415904 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.751G>A (p.Gly251Ser)	single nucleotide variant	not specified [RCV004078538]	Chr22:40019980 [GRCh38] Chr22:40415984 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.649C>T (p.Arg217Trp)	single nucleotide variant	not specified [RCV004209279]	Chr22:40019327 [GRCh38] Chr22:40415331 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.904C>T (p.Arg302Trp)	single nucleotide variant	not specified [RCV004232706]	Chr22:40021414 [GRCh38] Chr22:40417418 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1285C>T (p.Arg429Trp)	single nucleotide variant	not specified [RCV004188033]	Chr22:40021795 [GRCh38] Chr22:40417799 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1361A>G (p.Asn454Ser)	single nucleotide variant	not specified [RCV004188137]	Chr22:40021871 [GRCh38] Chr22:40417875 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.401G>A (p.Arg134Gln)	single nucleotide variant	not specified [RCV004174444]	Chr22:39995443 [GRCh38] Chr22:40391447 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1271T>C (p.Met424Thr)	single nucleotide variant	not specified [RCV004208986]	Chr22:40021781 [GRCh38] Chr22:40417785 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.448C>T (p.Leu150Phe)	single nucleotide variant	not specified [RCV004229474]	Chr22:39995490 [GRCh38] Chr22:40391494 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.490G>T (p.Val164Phe)	single nucleotide variant	not specified [RCV004241572]	Chr22:40019168 [GRCh38] Chr22:40415172 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.529A>G (p.Ile177Val)	single nucleotide variant	not specified [RCV004167769]	Chr22:40019207 [GRCh38] Chr22:40415211 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1310G>A (p.Arg437His)	single nucleotide variant	not specified [RCV004082212]	Chr22:40021820 [GRCh38] Chr22:40417824 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.511C>G (p.Leu171Val)	single nucleotide variant	not specified [RCV004188693]	Chr22:40019189 [GRCh38] Chr22:40415193 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.665G>A (p.Arg222His)	single nucleotide variant	not specified [RCV004071055]	Chr22:40019894 [GRCh38] Chr22:40415898 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.85G>A (p.Glu29Lys)	single nucleotide variant	not specified [RCV004091068]	Chr22:39995127 [GRCh38] Chr22:40391131 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.911T>G (p.Leu304Arg)	single nucleotide variant	not specified [RCV004169175]	Chr22:40021421 [GRCh38] Chr22:40417425 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1303G>A (p.Ala435Thr)	single nucleotide variant	not specified [RCV004205559]	Chr22:40021813 [GRCh38] Chr22:40417817 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1283C>T (p.Ala428Val)	single nucleotide variant	not specified [RCV004192253]	Chr22:40021793 [GRCh38] Chr22:40417797 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.877G>A (p.Ala293Thr)	single nucleotide variant	not specified [RCV004192609]	Chr22:40021387 [GRCh38] Chr22:40417391 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.848C>G (p.Pro283Arg)	single nucleotide variant	not specified [RCV004078162]	Chr22:40021358 [GRCh38] Chr22:40417362 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1085C>T (p.Ala362Val)	single nucleotide variant	not specified [RCV004257455]	Chr22:40021595 [GRCh38] Chr22:40417599 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.71C>T (p.Ala24Val)	single nucleotide variant	not specified [RCV004287357]	Chr22:39995113 [GRCh38] Chr22:40391117 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.909G>C (p.Gln303His)	single nucleotide variant	not specified [RCV004328668]	Chr22:40021419 [GRCh38] Chr22:40417423 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.553G>A (p.Ala185Thr)	single nucleotide variant	not specified [RCV004299890]	Chr22:40019231 [GRCh38] Chr22:40415235 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.54G>A (p.Val18=)	single nucleotide variant	not provided [RCV003433227]	Chr22:39995096 [GRCh38] Chr22:40391100 [GRCh37] Chr22:22q13.1	likely benign
GRCh37/hg19 22q13.1-13.31(chr22:39044105-45794212)x3	copy number gain	not specified [RCV003986179]	Chr22:39044105..45794212 [GRCh37] Chr22:22q13.1-13.31	pathogenic
GRCh37/hg19 22q13.1-13.2(chr22:39935185-41752098)x1	copy number loss	not specified [RCV003986188]	Chr22:39935185..41752098 [GRCh37] Chr22:22q13.1-13.2	uncertain significance
NM_138435.4(FAM83F):c.1109G>A (p.Arg370His)	single nucleotide variant	not specified [RCV004383519]	Chr22:40021619 [GRCh38] Chr22:40417623 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.223G>A (p.Glu75Lys)	single nucleotide variant	not specified [RCV004383526]	Chr22:39995265 [GRCh38] Chr22:40391269 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.988G>A (p.Val330Met)	single nucleotide variant	not specified [RCV004383532]	Chr22:40021498 [GRCh38] Chr22:40417502 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1094G>A (p.Gly365Asp)	single nucleotide variant	not specified [RCV004383518]	Chr22:40021604 [GRCh38] Chr22:40417608 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.122G>A (p.Gly41Asp)	single nucleotide variant	not specified [RCV004383522]	Chr22:39995164 [GRCh38] Chr22:40391168 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1339G>T (p.Ala447Ser)	single nucleotide variant	not specified [RCV004383523]	Chr22:40021849 [GRCh38] Chr22:40417853 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.373G>A (p.Asp125Asn)	single nucleotide variant	not specified [RCV004383527]	Chr22:39995415 [GRCh38] Chr22:40391419 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1221G>C (p.Met407Ile)	single nucleotide variant	not specified [RCV004383521]	Chr22:40021731 [GRCh38] Chr22:40417735 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.544G>A (p.Val182Met)	single nucleotide variant	not specified [RCV004383528]	Chr22:40019222 [GRCh38] Chr22:40415226 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1390A>G (p.Thr464Ala)	single nucleotide variant	not specified [RCV004383524]	Chr22:40021900 [GRCh38] Chr22:40417904 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1052C>T (p.Ala351Val)	single nucleotide variant	not specified [RCV004383516]	Chr22:40021562 [GRCh38] Chr22:40417566 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1159C>T (p.Pro387Ser)	single nucleotide variant	not specified [RCV004383520]	Chr22:40021669 [GRCh38] Chr22:40417673 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.932G>A (p.Gly311Asp)	single nucleotide variant	not specified [RCV004383531]	Chr22:40021442 [GRCh38] Chr22:40417446 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1428C>A (p.Asn476Lys)	single nucleotide variant	not specified [RCV004383525]	Chr22:40021938 [GRCh38] Chr22:40417942 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1469G>A (p.Ser490Asn)	single nucleotide variant	not specified [RCV004625639]	Chr22:40029531 [GRCh38] Chr22:40425535 [GRCh37] Chr22:22q13.1	uncertain significance
NC_000022.10:g.(?_39306081)_(41904073_?)dup	duplication	Rubinstein-Taybi syndrome due to EP300 haploinsufficiency [RCV004579118]	Chr22:39306081..41904073 [GRCh37] Chr22:22q13.1-13.2	uncertain significance
NM_138435.4(FAM83F):c.127G>A (p.Glu43Lys)	single nucleotide variant	not specified [RCV004625640]	Chr22:39995169 [GRCh38] Chr22:40391173 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.988G>C (p.Val330Leu)	single nucleotide variant	not specified [RCV004625641]	Chr22:40021498 [GRCh38] Chr22:40417502 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1358C>A (p.Pro453His)	single nucleotide variant	not specified [RCV004625642]	Chr22:40021868 [GRCh38] Chr22:40417872 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1440T>G (p.Ser480Arg)	single nucleotide variant	not specified [RCV004923551]	Chr22:40021950 [GRCh38] Chr22:40417954 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1450T>C (p.Ser484Pro)	single nucleotide variant	not specified [RCV004923541]	Chr22:40021960 [GRCh38] Chr22:40417964 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1037G>A (p.Arg346Gln)	single nucleotide variant	not specified [RCV004923542]	Chr22:40021547 [GRCh38] Chr22:40417551 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.853G>A (p.Asp285Asn)	single nucleotide variant	not specified [RCV004923543]	Chr22:40021363 [GRCh38] Chr22:40417367 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.479A>G (p.Gln160Arg)	single nucleotide variant	not specified [RCV004923544]	Chr22:39995521 [GRCh38] Chr22:40391525 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1387G>A (p.Glu463Lys)	single nucleotide variant	not specified [RCV004923546]	Chr22:40021897 [GRCh38] Chr22:40417901 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.757A>G (p.Lys253Glu)	single nucleotide variant	not specified [RCV004923547]	Chr22:40019986 [GRCh38] Chr22:40415990 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1399G>T (p.Val467Leu)	single nucleotide variant	not specified [RCV004923548]	Chr22:40021909 [GRCh38] Chr22:40417913 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.1267G>A (p.Gly423Ser)	single nucleotide variant	not specified [RCV004923549]	Chr22:40021777 [GRCh38] Chr22:40417781 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.848C>T (p.Pro283Leu)	single nucleotide variant	not specified [RCV004923550]	Chr22:40021358 [GRCh38] Chr22:40417362 [GRCh37] Chr22:22q13.1	uncertain significance
NM_138435.4(FAM83F):c.794C>G (p.Ser265Cys)	single nucleotide variant	not specified [RCV004383530]	Chr22:40021304 [GRCh38] Chr22:40417308 [GRCh37] Chr22:22q13.1	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	7200
Count of miRNA genes:	1394
Interacting mature miRNAs:	1885
Transcripts:	ENST00000333407, ENST00000473717, ENST00000488874
Prediction methods:	Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
407023536	GWAS672512_H	prostate carcinoma QTL GWAS672512 (human)		0.000004	prostate carcinoma		22	40040969	40040970	Human
407023537	GWAS672513_H	prostate carcinoma QTL GWAS672513 (human)		0.0000004	prostate carcinoma		22	40040969	40040970	Human
597162782	GWAS1258856_H	arginine measurement QTL GWAS1258856 (human)		0.000009	arginine measurement		22	40020021	40020022	Human
597280949	GWAS1377023_H	Uterine leiomyoma, breast carcinoma QTL GWAS1377023 (human)		1e-10	mammary gland integrity trait (VT:0010552)		22	40029970	40029971	Human

D22S1197

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	22	40,419,332 - 40,419,499	UniSTS	GRCh37
Build 36	22	38,749,278 - 38,749,445	RGD	NCBI36
Celera	22	24,221,378 - 24,221,545	RGD
Cytogenetic Map	22	q13.1	UniSTS
HuRef	22	23,382,596 - 23,382,763	UniSTS

D22S630

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	22	40,425,269 - 40,425,472	UniSTS	GRCh37
Build 36	22	38,755,215 - 38,755,418	RGD	NCBI36
Celera	22	24,227,311 - 24,227,514	RGD
Cytogenetic Map	22	q13.1	UniSTS
HuRef	22	23,388,525 - 23,388,728	UniSTS
Whitehead-RH Map	22	148.0	UniSTS
Whitehead-YAC Contig Map	22		UniSTS

D22S302

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	22	40,424,998 - 40,425,211	UniSTS	GRCh37
Build 36	22	38,754,944 - 38,755,157	RGD	NCBI36
Celera	22	24,227,044 - 24,227,253	RGD
Cytogenetic Map	22	q13.1	UniSTS
HuRef	22	23,388,262 - 23,388,467	UniSTS
Whitehead-YAC Contig Map	22		UniSTS

D22S299

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	22	40,425,040 - 40,425,227	UniSTS	GRCh37
Build 36	22	38,754,986 - 38,755,173	RGD	NCBI36
Celera	22	24,227,086 - 24,227,269	RGD
Cytogenetic Map	22	q13.1	UniSTS
HuRef	22	23,388,304 - 23,388,483	UniSTS
Whitehead-YAC Contig Map	22		UniSTS

AL021673

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	22	40,394,171 - 40,394,298	UniSTS	GRCh37
Build 36	22	38,724,117 - 38,724,244	RGD	NCBI36
Celera	22	24,196,216 - 24,196,343	RGD
Cytogenetic Map	22	q13.1	UniSTS
HuRef	22	23,357,111 - 23,357,238	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2424	2767	2212	4823	1652	2221	6	556	1381	397	2206	6581	5884	30	3642	1	799	1704	1554	174	1


RefSeq Transcripts	NM_138435	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AK126297	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK311584	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC011204	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC031099	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BE552004	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471095	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068256	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KF457465	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	Z82206	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	Z83847	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000333407 ⟹ ENSP00000330432

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	22	39,994,954 - 40,043,534 (+)	Ensembl

Ensembl Acc Id:

ENST00000473717 ⟹ ENSP00000476600

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	22	40,009,688 - 40,030,031 (+)	Ensembl

Ensembl Acc Id:

ENST00000488874

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	22	39,995,362 - 39,999,125 (+)	Ensembl

RefSeq Acc Id:

NM_138435 ⟹ NP_612444

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	22	39,994,954 - 40,043,534 (+)	NCBI
GRCh37	22	40,390,953 - 40,426,043 (+)	RGD
Build 36	22	38,720,899 - 38,755,989 (+)	NCBI Archive
Celera	22	24,192,998 - 24,228,085 (+)	RGD
HuRef	22	23,353,893 - 23,389,299 (+)	RGD
CHM1_1	22	40,350,160 - 40,385,346 (+)	NCBI
T2T-CHM13v2.0	22	40,465,916 - 40,515,097 (+)	NCBI

Sequence:

show sequence

GCCCCGCCCCTCGGCGGCTCCAGGTGCGGCTGTGGGACCTCGGACCGCGGCGGGGCCGGGGCCAGGGCCGGGGCCGGGGCCGGGGCGCCATGGCCGAGTCCCAGCTGAACTGCCTGGACGAGGCGCAC
GTGAACGAGAAGGTGACCGAGGCGCAGGCCGCCTTCTACTACTGCGAGCGGCGGCGGGCCGCGCTGGAGGCGCTGCTGGGCGGCGGCGAGCAGGCCTACCGCGAGCGGCTCAAGGAGGAGCAGCTGCG
GGACTTCCTCTCCAGCCCGGAGCGCCAGGCCCTGCGGGCCGCCTGGAGCCCCTACGAGGACGCCGTCCCCGCCGCCAACGCCCGGGGCAAGAGCAAGGCCAAGGCCAAGGCCCCCGCGCCGGCGCCGG
CTGAGTCCGGCGAGTCCCTGGCCTACTGGCCCGACCGTTCCGACACCGAGGTGCCTCCTCTGGACCTGGGCTGGACGGACACTGGTTTCTACCGCGGCGTGAGCCGGGTCACGCTCTTCACCCACCCG
CCCAAGGACGAGAAGGCGCCGCACCTCAAGCAGGTGGTCAGGCAGATGATCCAACAGGCCCAGAAGGTCATTGCTGTGGTCATGGACCTCTTCACTGATGGTGATATCTTTCAAGACATTGTGGATGC
TGCCTGTAAGCGCCGGGTCCCAGTGTACATCATCCTGGACGAGGCAGGAGTGAAGTATTTCCTGGAGATGTGTCAGGACCTGCAGCTCACTGACTTCCGGATTCGGAACATCCGTGTCCGCTCTGTGA
CAGGCGTCGGCTTCTACATGCCCATGGGGAGGATCAAGGGGACCCTGTCATCAAGGTTCCTGATGGTGGACGGTGACAAAGTGGCCACTGGATCTTACAGGTTCACCTGGAGTTCCTCCCATGTGGAC
AGAAACCTCCTCCTGCTCCTGACAGGACAGAACGTAGAGCCCTTTGACACGGAGTTCCGGGAGCTGTACGCCATCTCCGAGGAGGTGGACTTGTACCGGCAGCTGAGCCTGGCGGGCAGGGTTGGCCT
CCATTACTCCTCCACTGTGGCTCGAAAGCTTATCAACCCCAAGTACGCCTTGGTGTCAGGCTGCCGCCACCCGCCTGGGGAGATGATGCGCTGGGCTGCCCGGCAACAGCGGGAGGCGGGCGGCAACC
CGGAGGGGCAGGAGGAGGGCGCCAGCGGTGGCGAGTCGGCCTGGCGCCTGGAGAGCTTCCTGAAAGACCTGGTTACGGTGGAGCAGGTGCTGCCCCCCGTGGAGCCCATCCCCTTGGGAGAGCTGAGC
CAGAAGGATGGCAGGATGGTCTCTCACATGCACAGAGACCTGAAGCCCAAATCCCGAGAGGCACCCAGCCGAAACGGCATGGGAGAAGCGGCCCGGGGGGAGGCCGCCCCCGCCAGGCGCTTCAGCAG
CAGGCTCTTCAGTCGCCGAGCCAAGAGGCCTGCGGCGCCCAATGGCATGGCCAGCTCTGTCTCCACCGAGACCTCTGAAGTGGAGTTTCTGACGGGGAAGAGGCCCAACGAGAATTCCAGTGCTGACA
TCTCAGGTAAAACAAGTCCCAGTTCTGCCAAGCCTAGCAACTGTGTGATTTCCTGAGCTGCGGGATGGTGGTGGGCAGGACGTGTGGATGCCTGCCTGCCCTGCCCTGTGCTGTGGAGAGCGCAGGTC
GCACACTGCACCAGTTTGCACATCAGACGCCAACTGGCCTTCTGCCCTGCAGCCTCCGTCCTGGCCTCAGGGACGCTGGATCCCAAATGAGAGGGTCCGAAGCATCTCAGTCACACGCCTCCACCGGA
CTGTCGGTGGCTGGGCAGGGGTCAGTGCCACGGCCTCCTTGTTTACATGAAGTGGAAGCTTGACCAGTGTCTGCTCGCCTTTGTGCCCCACCCCCTCCGCTGATTGCCAGATGGGGTGAGGGCCCATT
CTTTAAACCTTTATGGGGTGGGGTGTCTGGGGCAGCTGCAGTGGCTTCTCCTTTCCCAGGCTTCCTGGTGCTTCTGGTTCCCCACGCCACTCCCCACCCAAGAGATTGGTGGAATAAAAGGGAAGAGG
GCAGGGCCCTGAGCCTGGGATCCCAAGTTCCAGTCTTTCTCTAGCCTCTGAACTCCAGATGTAAGGTGCAGCTGGAACTGCAGGGGCACTGGCTGCAGTGGCCTTCCTGGCCCCATCCCTGCAGGCTC
CTGAACTAGACTTGAATGAGGGTAAGATCCTGCGGCCTCCCGCAGTGGGGGCAGAATTTGACACTGCTTTTCTGAGAGCGCTCGCACTGAGGTCTCTTTTTCCCTGCCCAGTGCCGTCCTGGCAGTCT
CGGCATGGGTGGTTGAGACCTCCTTGGCTGCTGCCTGCTGCGGGCCTATGTGGGGGTCCTTACAGGGCCTTTACCTGGGACTGCTCCTTCCCTCAGTCAGTAAACTTTGGTTTACAGCCCAAGGCAGG
GAGGGAGCTTGGCTGAGAGGGGATTGGGGGTGTGGGAGGCTGGGCCCTGAGGACAGGAGCATTTGCCTTTTCTCCCTCAACTCTAACGGGGTCCTCGGACCCCTTCACCAACCAGGGCTTCCAGGTTA
CACTTTGGCCAGACTGGCCTTTGCCTCCTGCGAGAGTCAGGCCATTTTTAGGAGCCTGTGCCTCGCCAGAGCAGGTCAGCCTAATGGCCATGAGGCTGAGCTGGGAGGCCCAGTAAGCAATTCCATTC
TGCCTTCCCCACTTGGGTGACTGGAGAGGGCCGAGGAGAGTTTGTGAATGGACCTGGGAGAAATTGCCAAACTGCAGACTCTGTGAGCCGGCCCTGCCGGCAGGGCGATGGGGGATCCAAGCCCTGTG
GAAGAGCCATGCAGCGGACTTTCTTGCCCTCTGACCTCTGAACCAAACTCTCATCCTCTTTCTTTCCTTCTAAAAAACCCTAGGACACTACCAGCACCTGGGGGAGGGGTACAGATGTCTGCAAGGCA
GCTGATGTGAGAGCAAGAAAAGGGGCTGCTCTGGCTGGGCTGTGGGAGCCAGGCATTGCTTCTGAGGAAGCAGGAAGTGGGGACCACATGTGGCGGCCATTGAGGAGATGCAATCTCTCTGGCAGTGG
GGAGGGGAAGGGAAAGGAAGGGTGAGCCTGTCCCCAGGGTCTTCTCTGTTAATCCCAAGGCTGGCTTCTAGGGCGTGTGGAGAAGGGACTCTGGCCCACCTCCCTGAGCTTTTATGAAGGTGAAATGC
TTCTGGGAAGTGTTTCCTTAGGCACCAAGACCAGGCAGTGTGGCATGAGCTCATTCTGGAGGGGAGGGAAGGGAGAGAGGGGGGAGGTGGGATGTGGGGGTGTTACACCTCAGCTCGAGGCGGACACC
TTGAAGGTATGGGACATGAAATGTGTAAACTGCAACGCGGCAAAGAGATCACTCTCTGGTGTGGAGGGTGGGTGTCTCTGGGGATTAGGGAGGCAGCCTGGGGAAGGGACCGGCCTCCAAGCAAGTCA
GCCAAGGGCATCTGTGCCTCCCCTGCCAGAAGAGCAGGCCCTGCTTTGTCCCTTTACCTCCTCTAGGCCCAAAGCACACCCAGGTCCCTCCCCTGCCCTGACATCTAATCTGGGAGGATCCCTGATTG
GAATCTCCAAGTCACCACAGCCTTGAGCCAGGCCTTCCTTTCTGCCTCAGTTTCTCCATGTGCCAAGATGGCGTTTTTCACACTTTCTTGGTAGAAATGATGGGGAGACCATATGTTAGGAAGCAAGT
TGGCATAGTGGGAAGAGGGCCAGCCACAAGGCAGGAGTGCCCAGGCAGGGTGCCTCTCCCTGCTGGCCTGTGTCCTCGTCCTTATAGCAGTGTGGACAAGATGGTGTCGGCACCCCCCGCTCCAAAAG
GCTTGAGACAGAAACTGTAGTCCGAGATGGCAAGGATTTTGAACTCACAAAATGCAGCTCTTCATGTTTGCCTGTCTGCCTAGGCACCGGCCCACTCTGTTCTGCCTCTTGGCTTCTCAGCTGTGAGT
ACGCCTGCCCTCTGTTCCAGCACTTGCACATACTTTGTGAAGCAGTCTCTTACTCATCAAATCTCAAGGGTACATCTGGCCCTCCCAGTTGGATGGCAAGTTCAAGGGTGGATCATGCCCTTGGTCCC
TGCACAGCAGCTTCTGCAAGGCTGGTTACATTGGAAGGGCTCTAGGAGGAACAGGATAAGGCAGCACTCTCGGGGCTGGGGTCTGGCTTCACTGCACCCCCCTCCCACCCCACACCACCACCAAGCTG
CTGTCTTTCTGAGTCAGCTTCTGTAGGGTAAGTGTTCACAGCTGGTGCAGCTCTTTGGGAAACCTAACCTCCCAGTGAGCTGAGCCCCTGGTGCGGCCGCCACGCTTGCTTCTGCCCCACAAGGGCAG
TAAGCACAGGACTTCTGGATGGATCTGGGAGCCTGCCCCTTGGGATTTGGCAAAACTTCCCATCTCCTTAGCTACCTGTCCTTAATCTTATCCCTGACCCCTCGAGGGCTTTCAAGATAGCCTCTGTT
AACATCACTACCCTCTGCCTGTGTAGAACTTTATAGAAAGGCTAGGCAAAAAATGAGACCCAGAGATATGGAAGAAACTGGCCAAAGAGGGGAAAGTGGGCTATTTCTTTTTTTTTTTTCTTTTTTTT
TTCTGAGACAGAGTCTCACCCTGTTGCCCAGGCTGGAGTGCAGTGACAGCGATCTTGGCTCACTGCAAGCTCCGCCTCCCGGGTTCACGCCATTCTTCTGCCTCAGCCTCCTGAGCAGCTATGACTAC
AGGTGCCCACCACCATGCCTGGCTAATTTTTTTATATTTTTATTAGAGACAGGGTTTCACCATGTTAGCCAGGTTGGTCTTGATCTCCTGACCTTGTGATCCGCCCGCCTTGGCCTCCCAAAGTGCTG
GGATTACAGGCCACCGTACCCGGCCAGGCTATTTTTTTGTTTTGTTTTTGTTTACTACTGTATTGCTTTTCTCTTTTTCATATTTATTGAGCACCTACTATATGCCAGTCACCATGCTAGATGCTTTA
GTAACATGAAGGTTTCAAACTAAGAAAAGCTCAACAAAGAGCCCTTTAGAAAGGTAACAGTTTTCCTGTGTATTGGGGGAGTGGGTCTCATAAGGTTGTATGATGAGAAGCGCAAGTAATTGTTTTGT
TTTTTTTTTGAGACAATGTCTTGCTCTGTCGATCAGGCTGGAGTGCAGTGGCGTCATCTCAGCTCGCTACAACCTCCACCTCCTGGGTTTAAGTGATTCTCTGGCCTCAGCCTCCTGAGTAGCTGAGA
TTACAGGCACGCGCCACCACGCCCGGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCACTATGTTGGTCAGGCTGATCTTGAACTCCCGGCCTCAGGTGATCTGCCTGCCTTGGCCTCCCAAACT
GCTGGGATTACAGGCATGAGCCACCACGCCCAGCCTGGCTAAGGTTCATTATCCCCATCTTTCAGATGAGGAGGCACACAACTCTCCCCAGATCCCACGTCACAGAGAATGCAGGTCTGAGTCTGTTC
CTTGAGCTCAGGGTCTTGGCAATGGTGATGCTTTGGAGCTGCAGAATCCTCTGTTGGGGATGGGGCTGCCCTGTGCATTATAGTACGTTTAGCAACATCCCTAGCTTCCACCTACTAAATGCCACTAG
CACTCCTTCAGATGAGACCACCAAAAATGTCTCCAGATGTTACCACATGTCCCCTGGGGGGTAAAAGTGCCCCCGTTGAGAGCACTGGCTCTTTTCTTCACAGTCCTGACCTGGTGGCCTGCACAGGC
CACTTCTCCGAAGTGTTTCAATGCACTCTCTGCCCTGGGTACCTTGGACACAGCACCCTGGCCCAGAGAGGTTGGCTGACTTGCCTGAGACGCTGCTTCCTGGGAGACGCAGTAGCATCTTTCCTTTC
TGTTCTGGTTATCTTTCTTAGTTCTTTACCACCTTATATTCCCCATGACAGGTGTGTTTATGTACACACATCTGCCTCACTCCACTCAGCTCCCTGTCAGGTTTCCTGCCAGTCTGTCCCTCTTCCTT
CAGGCTCAGCTACGTCCTGCACAGACAGTACCACTGCACATACCTGTGTGTGCCCAGCGGTGGACCCACCTCCAAAAGCAGCCAGTGCTGACAGCAGAGAGCCTTCCACACTCAAGTCAGGCCAAGCA
GGAATCGCTACCTGCCTGTCATGACCACATTCTCAGTGAACATTGACAAAGCCCCCTTAGCAGCTAATTAGCCCTGCCGTGCGCTAGGGATGCAATTTCTCATCTGGCAGTGCGCCACACTCCTGCCT
CCCTGCCCAAAGGACGTAGTGGCTGCTGCTGATCGTCTGCACTGCTGTTCCAGGGGCAGGAGGTTTGCTGCAAATCAGGTACCCCCAGCTCAGTGAGCAGAACCAGTCCAAGGTTGAGTGAGGAGAAG
GGCAAGAAGGGCAGGCACAGCCGTGAGTATGTTCTGGGGCTAAGTAACCATGAGATCAGCCCAGAGACCTTGCACAGTTAGGCAGGCCTGGACTTCTCGCCCTTCCCCTTGCAGCTTCTGCTCTCCCA
GCTAGGGACTGAGGAAAGCCCTGCTTCTAGATGCCATGTGCTGCTGCCTGGCACGATAGGTACCCATCTGTCCTTGGGGTTCCTGAGCCTGGAGAGCGGGCTTTGTGAGCACTGGTGCCTCACCTGCC
TGGCTCAGCTCTGCAGCCACAATATATGCTTAATACCTATTTGTTAAATGATTGAAGACTTGACTGCCATTCAGTACAGAGAATTAGCCAGGTGAATAAACAGGATGTGTCATAGAGGTTCTAGAATT
GATCATGACCCTTTCTGTCTCATTCCTGACTTCTAATACCGTATATGCCAAATGGGGTTCTGCTGTGATTTAATTTCTTAAGGACTGGGTTTATCAAAAGTCCCTCCTGATCTAATCCTTTCCTCTAG
GAAGGCTTCTCCTTTCTTCATCTGTCCTAAGTGCATGGTCTTCATCTCCTGGGTGGTCCAGACTAGGTGGCACTGGGCCTGCAGGCCTCTAGCTGCTCAAGGATGGCCCTGTCTGCATGCTTCCTTTC
AAAAGCTAGCATAGAAAGGAGGGCCCAAGGTGAGGAAATTTGTCCAAAGTCACCCAATGAGTCGCAGGAAGGGCTAGAATCTGGTTATCTGGACCGTCCTAGAGCACTTTCACAGTGACAGCCGGCTG
GAATCAAGTTTTCATTTAGAAAAATGGCTAGAAGTTAGGGCATTGCCTGCAGCCACTGAAAAGCAGCTTTAGGAGCAGATGTCCACGTAATAGAAGGAGATGGGCTAGGGCCTGCCACGGAAGCCAGC
AAGCGCGTGGGAGCTGGGGGAGGAAAGGAGCAAAAGGCAAGAACAGGCAGTATGTCCGCGGTGCCCACAGTGCTGTGGGTACAAGCAAGGGGAAAAGAGCCCATGGTGTGCAGAAAACCATGCGTCAT
GATTCTTATTTCCTGCTCGCAGCTTTGACTCTCTGCCTCATCTCTTCCTGGAAGTGTCTTGGAAGTTAGGCGACTGCACAGGGAAAGGTTCGCTGCAGTGCTTGCAGGCCTGCACCCATTTATTCATC
CGGTGGATATTTGCTGGGTGCCCGGCCTGGGGATCCATGGTGAGCGAGGAAGGCATGGTATTGAAGTGGTATGCCTGCATGACCTTGGCGGGGGCGCATGGCATAGAGAGGACAGGCTTCAGAACAGG
CAGGCAAGGGCTGAAATCCTATCTCTGCCACCGAACAGCTAATGACCCCAGCAAGCAATTTCACATCCCCGAACTTTCCTGTTTCCTCATGTGTCAAATGGGGATGATCTCGAGACGACTCTCCAGAG
TAACCACGTGAAGCACCTAGCACAGGGGCTGACGCAAACAGCTGGGCATCGGAGGAGCCTCCAGGGTTGTGACCTCCAGTGGCTTATTTTCCTTTTGGGATCTTCTCTCCTAGATCCTCCCCTTTAAT
TCCCTGTGAAATTTACCACTTTCATATTGAATCGTTGGCACACAGGGCTAACTGCTTGTTCACCTGAAGGAAGCTACAGAGTTCAGGTTTCTTTTTTCTTTCTTTCTTTCTTTTTTGCTTTTTTAAGA
TGATCTTGCTCCGTCACCCAGGCTGGAGTGCAGTGGCGTAATCATGGCTTCCTGCAGCCTCAAACTCCTGGGCTCAATGAGTTCCTTGAGATCTTCCATCCTCAGCTTCCCAAGTAGCTAGTAGTAGT
AGTGGCTTGCACCAACGCTCCTGCCCTAATTTTCAATATTTTTTTGTAGAGATAGGATCTCACTGTGTTACCCAAGCTAGACTTGAACTCCTGGCCTCAAGCGATCCTTCCGCCTTGGCCTCCCAAAG
TGTTGGGATTACAGGCATTAGCTACCACACCTGGCCAAGGCCCAGGTTTCGACAGAAAGGGAGAGAAAACCTGCCAGAGATGCCATTTCGGAGCCACTCTGCTTGGCAGGGACCTGTGTTCCCCTCAT
GCAGGTTCATCCTTAGAGGGCTGCGGTCTTATCTGGTTGTGCAAAAGTCCCACAACCTTTCTGGATTGATAGTTTGTGGTGAAATAAACAATTTTAGTTTGTTTGGAGAATCTTTTGTATACAAAATA
CAAATAAAACCTAAATCAAAGAAACAGAGCATGTCCGGAGAAGTCTGCCAACCCTTCTCCAGGCCATGGGGCTTCCCAAGCCAGGCCTGTACTCCTCATGTAGATTCCACACCCCGCCTTGATGTCTT
TGGCTTTCACACTAGTGACTATAGCCTGGTGGGACGGGGTCTAGGGGCCACAGTCCTGGTCCTGCGCAGGTGGCCCTGGAGAGAAGCCTTGGAGAACTTGGAGAAGCCCACGCGGCTGGCAGCATCAT
GGTGAGAGGCTGACACCTTGTGGCTGGCTGGCAGCATACGTCCTTCCTCCCCTAGGTCAGCTAGACGGCCAAAGCAGGGATCTGCAAGCTCCTTCTGTGGCGGGCCAAAAAGTGAACATTCAGTGTGT
CTGTTGCAGCTACTGTCATAGCACTGAGGCACCCCTAGACAGTACAGAAACAAGCAGGTGTGGCCATGTTCCAGTGAAACCTTATGAATACTGAAATCTGAATCCATAATTTTCATGTATCACAAAGT
AGTAATATTCTTTTAATATGCAAAAACCGGCCAGGTGCGGTGGCTCATGCCTGTGACCTCAGCACTTTGGGAGGCCGAGGTGGGTGGATCACCTGAGGTCAGGAGTTCGAAACCAGCCTGGCCAACGT
GGTGAAACCCTGTCTCTATTAAAAATACAAAAATTAGCCTGGTGTGGTGGCACATGCCTGTAATCCCAGCTACTCGGGAGGCTGAGGCGTAGGAATTGCTTAAACCTGGGAGGCGGAGGTTGCAGTGA
GCTGAGATCATGCCACTGCACTTCAGCCTGGGCAACAGAGCTAGACTCCATCTCAAAAACAAACAAACAAAAAAACAAAAGCAAAAACCAGTCTTAGCTCACAGGCTGTGCCAAAACAGGCAGTGGGC
TGGATTTGGTCCTCAAGCCTGGGCTTGCTGACCTCTGGCCTAGGACACCTCTCCTTTATGCCTCCGCTCCCAACACGGACTCTCAACTCTCATGTTTACCTTGTCATTGTTCTGTCAAGAGGAATTCA
CTAGTCTCACTCCTCCAACCAGACCGCTGCCACTAAGGCTTCTTCTGAACAGAAATTCTGGATTTGTTCTCACCCATTTCATAAATGTACATAAGCACCCATCAGGTGCCAAGCCCTGTGCTGAGATG
CCTGCAGAGCCCAGAGTTTTCACCAACTTTTTTTTTAAGAGATGGGGGTCTCTGTTGCCAGGTTGGAGTGCAATGACATAATCATAACTCACCGCAACCTCAAACTCCTAGGTTCAGGTGATCCTCCC
GCCTCAGCCTCCCAAGTAGCTGGGACTACAGGCATGCACCACCCTGCCCAGCTAATTAAAAAAAAAACTTTAGGGATGGGGTCTTGCTATGTTGTCTAGGCTGGTCTCTAACTCCTGGGCTCAAGTGA
TCCTCCCACCTCAGCCTCCCAAGTAGCTGGGCTTACAGATGTGAGCCACTGCACCTGCTCAACATTTAATTTTTTCATTCATTCATTCGTTCATTCATTTGTTCAAACGAACTTATTGAGAACTTACT
GTGTTCCAGGCACTGTGATAAGATAGACCTGGCCTTTACCTTCAAATGTTCAGAACATGGTTAGGAAGATGGATACTGGGAGGCAAGTGTTCTGATGGGAAAGCACAGCATGTAAAGAAGCCCAGAGG
AGGCACTTAACCTGGGGGAGAAGAACAGGGTAGGCTTCCTGGAGGAGGAGGTAATCTCTGAGCCGATACCTGAGGAGTGAATGGAGGAGGGGACAATGAGGCAAGGCATTCCAGGGAAAGGTCCAGAG
CCTAGACAGAACTCTTTTAGGAGAATTATGAGAATCACAATTATCGAGGACACAGTGAAGACTCAGATAACTCAAATATAGGTTTTGCCCGCAAAGCCTTCCTGTCTGGTGGGTGAGACAGTCTACAG
CAAGCTGCTCCAAGGATATGGAGAAAAAAGTTTTTCCTCTGGCCTTGTAGGATTGGTTATTACTGAGCCTGGAGTACGCAAAGGCCAGCGAGTGCTCCTAAGGCAGGGAGGGGGCTGCCTTCACTATG
GGTGCTCAGGAAATCTGCCAGGGGAAGGGAGATGTGGGCCTGCCTCGGCTGCAGAAACCCCTCAGAGGAGGAGGAGGGGCTTGAACTGAGCTTTGAAGAAAGTGTAGACTTGGGGACAGGCAGAGGAA
GAGGGGGCATCATAGGCAGCAGAAACCACATGGACAAACTCTCTGCCGGAGAATGGGCATGGCCGGGCTGAGGGGTCCCTGGACAGGAACCAGCCTTCCCTATGCACCTGCACCCGTGAGTCTCACAA
CAGCCCCAACAGGCAAGTGTTATTTTCCTCAATTCTACCAATTAAAAACTGACCTTGGGCAACTGCTTAACCTATCTCTGCCTTACTTTCTTCATCTGTATCTACCTCAGAAAGTTACTATGAGGACT
GAATAAGCTCATACATATACAATGCTTGGAGCAGAGGCTGGTACTAGAGCTGGCTTCATGGGCATGAAACCTGTGAACACAGAACCCCATGCTTTCATTTTCCACTTAGTCCTGCCTGGCATAGTATG
CAGTTTTTTTAATTTGAGATGGAGTCTCCCTTTGTTGCCCAGGCTTGAGTGCAGTGGCGCGATCTCAGCTCACTGCAACCTCCACCTCCCAGGTTGAAGCAGTTCTCCTGCCTCAGCCTCCTGAGTAG
CTGGGATTACAGGTGCGCGCCACCATACCCAGCTAATTTTTGTATTTTTAGTAGAGATGAGGTTTTGCCATTTTGGCCAGCCTGGTCTTGAACCTCTGACTTCCATGATCCACCTGCCTCTGCCTCCC
AAAGTGCTGGGAGGATTACAGGCATGAACCACTACGCCTGGCCTGGTATGTGGGTTAAAATGTTAGGTTTTATCATTATCTTAGGTGGAGAATAACAAATCCGATTCAATATATTCATTTTAGAAACG
AGGAAACTGAAGCTTAGATAGTTTGTGTGACTTGCAAAAAGTCACGCAGCAAACAAGCTGCAGAATGAAGGGTGGAGATGGAGAGATAGAATTCTCATCTTAGAGGTGAAAGTAGGATAATGACCCAG
CTGAGCTTGCTGAGTCCTGCGAGCGTCGCACGCCCCCAGAGACAACATAAGGAGAGAAGTGCAGACAGATTCCTTTGAAGGAGCTTAGAGAAAGAGATGGTAGGGAAAAGAGCATGAACAGTTGTAGA
GGTAGGAGGAAAGCTGGCTATTTGGGGAAGCAAAGAAAAGATTCTCAGAGTAAAACGTATTGGTGAAGCCATGGAAACAAGGACTGAGAAAGTCTCTTGGATCTTGGCCACAAAAAGGTTATAGATGA
GCTTAGAGAAATGAATTTCAGTAGAGTTAGGGCTAGAAGCCAGGTTCAGAGAGAGAAAACGAGAGAGCATTCCTGGTGGTGGAGATGGCCGCAGGCCATTATTTAAAAAGCTAGGATAAGAAAATAGA
GAAGAAAGGGAAGGAAGCTATTTGAAGGGAGTGGGAGAAAAGCCAGATCTCAGTTGGGACGTGGAGGAAGGACCACCAGAGGCAGTAATTTAGCCGGAAAGAGGTGTATTTCTTTCCTTGAGTTTATA
GGGGGTAAAGAGGATGGGGCTGAGATACTAAAGACTACGAGGACAACTGTTCATTGAGGGCTGGTCATCTCCCCAGCTGCACTGTGGGGTTCCCAAGTCAGACATCCCAGAGGCAATATAGCAGCGTG
GACAAGAGCTTACTCGTTGGAGTCAGACCGCCTAGGTTCAACGATGGGTTAGTTAGCCCTTCAGTGCCTCCATTTTCCTATCTAGAAAATGTGGATAACAATGGTTGTTGTGAAGATTAACAGCCATA
ATCCACGTAAAGCCCTCAGTACAGTGTATGACACACAGCAAGTGTCCACCAAAGGGTAGTTATTATTAACCATAATCCTGGTTCTCTTGTGAGCTGCCTCCTGTGTGTCTAGCATTGGCCAGCACACA
TGAGGGGGTCCAGTGTTTGCTGCTTAACTAAGTAGCTTCTCAGGAAGTGTGGTCATAAAAAATGATAGGTGATTTAGAAGGTGAGACAGACACAAGGGATGTGTTGCACAGTAAATGCTCCCAGACAT
GCAATAAATGCTTATAAGCATGCCCTCTGTAATCAGCCCTCTTTAGAGAGTTTCCCTGCCTCATTGCTCTTGGTCTTTGGCAATGGCTACACCCACTGCCCAAGCAAGCAGTATCAGCTGTCAGCTGT
CCCCTTGTCTTTTGGATCAGATTCCTTTACAGGGATCTTCCCATTGTTATAAGCTTCAAGAATTGGAGAATGCTTAATGAACACTTCCAAATTCTTCATAGCTATGAGGGGCCAGTGCAAAGGGCGGA
AGGAGTTCTTCTGTGTCACAGAAATTAGAGCTGGAGCAGATCCAGCTTGCTATCCCCCCTTCCCCCAGCTTGTGGGTTATTGCAGAATTGTTCACAAAAATTCCCATTGCCTTGGAATTTGTCCAAGC
CGAGGGCAGGGATCACAACACAACCTCTCAAGGGAAAAAAGGAAGGCCTGTTGCTTGAGATGGCTCAGAGCACTTTTGGTAGCCAGCCAAGGCAGCTATCACTCATGAAATCTGCCTTCCCCTCCAGC
AAAAAGCCAACTGTATAGAACACCACATATAGAGCGCTAAGAATAGCACAGCGCTCCAAGAACATAGTGCACTTGGCCTGCATACAAGTGTGCAGGGCTTAACGAGTCTTTTTACTCTGAAAGCTGGG
TGGGTTGGAACAAACAAACAGAAAAATATTTTCCCCAAGTAGCATGCAGAGAGGAAATGAGAGCAAGCACAAGAGAGCACCCTGGCATAGCATTCTCTGACCTGGGCTGCCTTTTCAGGGTATGAGTT
GATTCCGCAGGCACCAAGGCATGCCTGTAAGCCCTACAGGGCAGACGCCCTCACCCCAATCATTGGCTTAACATTCACACCAGGCTGAGTAAGCCCCAAAAGTCCTGCCATTGGCTCTGACAGGAATT
GAAACCCATCTTCTCCACAATAAATATTTGATTGACAGATTGGCTTCCTTCCTATAAGTATAGAAAGCGAGGGCAGGTTCCATCCAAAGCCGCAGTTCTGGGTGATGAGAGCTCTGAGAGCCCAGAAA
AGACCCTGAACCACATCCCACTGTTTGTTGGAAGAAGAAACTCATTTGTGGGTCTGTTCATAAAAGAGTCTGGGAAGATAGTCTCCTTAACAGTGTCTGGATGTAACAGACTATGGGCGGCTTTTACT
TTATAACTTTCTATATTGTCTGAAATACAGAATATTAAATATTGAGTTAATATTATATTTACTCAATGTTACTTTTTTTTTTTTTGAGACAGGGTCTTGCTCTATTGCCCAGGCTGGAGTGCAGTGGT
GTGGCTCACTGCAGCCTTGAACTCCCAGGCTCAAGCAATCCTCCCACCTCAGCATCCCAAGTAGCTGGGACTGTAGGCGCAGGCCACCATGCGCAACTATTTATTTTCTTTCTTTTTGTAGAAATGGG
CTCTGCCTGTGTTGCTCTAGCTAGTCTCAAGCTCCTGGCCTCAAGCAATCCTTCCGCCTTGGCCTCTCAAATTGCTGGGATTACAAGCATAAGCCAATGTGCCTGGCCTCAATGTTACTTTTATGATC
AGAAAAACGGCCATCTTATTTGGAAATTATTTTCCTATTCTCAAGTGGGCAAATAGGAGAAGGTTTCAGGCATTTGTTTTGTCTCTGGGAGGGAAGGCACAATGAGGTGGAGTGGACAAATTGCTGAG
GCCTTTATGGACAAAGATTCTAAGAAGAACAGGCTTTGGCCATCTCTGGATATTCCCATTCTGCTCCCTGCCACCAGAGAGCAAATGTCGTAGGTCACCACACATCACCAGTCTCTTGCCTAGCTAAC
CGTAACTCATTCTTTAGTTCTCCTTGAAGGTGTCACTTCTTCCAGGAAGCCATTTCTGTCCCTCCCGAGATGGAGTCCCATGTCCCTACCATTTGCTTCCAGGGCACCTTCTCACAGCACTGCATCAT
GGTTATCTGCTTATCTGCTGGACACCCCTACTCGACTGAGGTCCTTGAAGGAAGAGAGAGTGTATCACTCATCTGCATAGCCTTTGTAACTTAGTAAAAGTGCCTGACATGCTCACTAAACATTTACT
GAGTAATTATTTATTTGGGGGCCTTTTACGATCAGAACAATGTGAAGGACACAAAGATGAAAAAGAAACCATCTGCTTCAAGGTACTTACAACTGAAATGTATCAAACAATTACCCAGAAAGTCAAGC
ACCAACTTAAGTGCTAAAATAGGGGTCCAAGCAACCAACTTTGAAGATTAGGAAGGTTTTAGATTCTGAATGTTTCTCATTCATTGTGTTTTTGAGTTCAGAATCCCCATACTGGAAGGCTAATATGG
GGTATGTGCATACAATTTTAAGGACTCACGTTCTTACAACCTATATTAGAATTTGACGCACGATCTTTCTTCTGTCCTTCTTGCAGTTGCCCTAGGAATACATGCCACTTACTCTTAATTGACGTTTA
TGAAATACCTTGGCTTCATTTGCTGAAAGGCTCTAAGTGTTGAGCATTGTTACTATGTTACAATGGTTGTTTTATTATTAAAGCAGTGCCAAGGAGGTTACACAACAGCTTGGATCAGGAAGTGAAAC
AAGGGCGGTGATCCCACTGAAGCTACAGGGGATGGGGATTTGGGACGGTAAAATGTTAATTACCCAAGATGGAATGTGGGCTAGAGTCCAGCGTTGTGCTCCTGGAGATCATTTCGGTCGCAAAAGCT
CACTGGCAATGGGTCCTAAGCGTCCTGCCCTCCTCTGGCTGAAATGTTGGATTCACTTCGATGAATGCTGCTATAGGGAAAGAACCCAGTGGCCACCAGCCAGGAGCACACGTCTTGCTCAGCATCAA
CTATCCTGGAAGATTTCCAGGAGCTGAAGGGCTGTTCTCTTTGCATGCAATAAATTATTCATTTCTAAGACGA

hide sequence


Protein RefSeqs	NP_612444	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAH11204	(Get FASTA)	NCBI Sequence Viewer
	AAH31099	(Get FASTA)	NCBI Sequence Viewer
	EAW60365	(Get FASTA)	NCBI Sequence Viewer
	EAW60366	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000330432
	ENSP00000330432.5
	ENSP00000476600.1
GenBank Protein	Q8NEG4	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_612444 ⟸ NM_138435

- UniProtKB:

Q96FD6 (UniProtKB/Swiss-Prot), Q8NEG4 (UniProtKB/Swiss-Prot)

- Sequence:

show sequence

MAESQLNCLDEAHVNEKVTEAQAAFYYCERRRAALEALLGGGEQAYRERLKEEQLRDFLSSPERQALRAAWSPYEDAVPAANARGKSKAKAKAPAPAPAESGESLAYWPDRSDTEVPPLDLGWTDTGF
YRGVSRVTLFTHPPKDEKAPHLKQVVRQMIQQAQKVIAVVMDLFTDGDIFQDIVDAACKRRVPVYIILDEAGVKYFLEMCQDLQLTDFRIRNIRVRSVTGVGFYMPMGRIKGTLSSRFLMVDGDKVAT
GSYRFTWSSSHVDRNLLLLLTGQNVEPFDTEFRELYAISEEVDLYRQLSLAGRVGLHYSSTVARKLINPKYALVSGCRHPPGEMMRWAARQQREAGGNPEGQEEGASGGESAWRLESFLKDLVTVEQV
LPPVEPIPLGELSQKDGRMVSHMHRDLKPKSREAPSRNGMGEAARGEAAPARRFSSRLFSRRAKRPAAPNGMASSVSTETSEVEFLTGKRPNENSSADISGKTSPSSAKPSNCVIS

hide sequence

Ensembl Acc Id:

ENSP00000330432 ⟸ ENST00000333407

Ensembl Acc Id:

ENSP00000476600 ⟸ ENST00000473717

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q8NEG4-F1-model_v2	AlphaFold	Q8NEG4	1-500	view protein structure

RGD ID:

6799980

Promoter ID:

HG_KWN:42909

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell

Transcripts:

NM_138435, OTTHUMT00000321289

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	22	38,720,241 - 38,720,741 (+)	MPROMDB

RGD ID:

6799981

Promoter ID:

HG_KWN:42910

Type:

Non-CpG

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

HeLa_S3, Jurkat

Transcripts:

OTTHUMT00000319623

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	22	38,734,816 - 38,735,917 (+)	MPROMDB

RGD ID:

13604186

Promoter ID:

EPDNEW_H28277

Type:

initiation region

Name:

FAM83F_1

Description:

family with sequence similarity 83 member F

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H28278 EPDNEW_H28279

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	22	39,994,954 - 39,995,014	EPDNEW

RGD ID:

13604188

Promoter ID:

EPDNEW_H28278

Type:

initiation region

Name:

FAM83F_3

Description:

family with sequence similarity 83 member F

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H28277 EPDNEW_H28279

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	22	39,995,457 - 39,995,517	EPDNEW

RGD ID:

13604190

Promoter ID:

EPDNEW_H28279

Type:

initiation region

Name:

FAM83F_2

Description:

family with sequence similarity 83 member F

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H28277 EPDNEW_H28278

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	22	40,009,699 - 40,009,759	EPDNEW

Database	Acc Id	Source(s)
COSMIC	FAM83F	COSMIC
Ensembl Genes	ENSG00000133477	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000333407	ENTREZGENE
	ENST00000333407.11	UniProtKB/Swiss-Prot
	ENST00000473717.1	UniProtKB/Swiss-Prot
Gene3D-CATH	Endonuclease Chain A	UniProtKB/Swiss-Prot
GTEx	ENSG00000133477	GTEx
HGNC ID	HGNC:25148	ENTREZGENE
Human Proteome Map	FAM83F	Human Proteome Map
InterPro	FAM83	UniProtKB/Swiss-Prot
	FAM83_N	UniProtKB/Swiss-Prot
KEGG Report	hsa:113828	UniProtKB/Swiss-Prot
NCBI Gene	113828	ENTREZGENE
PANTHER	PROTEIN FAM83A-RELATED	UniProtKB/Swiss-Prot
	UNCHARACTERIZED	UniProtKB/Swiss-Prot
Pfam	FAM83	UniProtKB/Swiss-Prot
PharmGKB	PA142671853	PharmGKB
Superfamily-SCOP	Phospholipase D/nuclease	UniProtKB/Swiss-Prot
UniProt	FA83F_HUMAN	UniProtKB/Swiss-Prot, ENTREZGENE
	Q96FD6	ENTREZGENE
UniProt Secondary	Q96FD6	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2015-11-24	FAM83F	family with sequence similarity 83 member F		family with sequence similarity 83, member F	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar